Angelika Joos,

Director DIA
Executive Director, Global Regulatory Policy
Merck Sharp & Dohme (Europe) Inc.

Angelika Joos has been responsible for Regulatory Policy issues within MSD's Global Regulatory Affairs and Clinical Safety department since 2001 and currently heads the EU office in Brussels. In her current position as Executive Director, Global Regulatory Policy, she oversees activities in Europe, Middle East, Africa and Asia-Pacific. Her role includes identifying regulatory policy priorities that align with MSD’s business priorities and leading cross-functional expert networks to define policy positions. She also informs the company’s regulatory strategy development by providing perspectives on the external environment evolution into MSD’s regulatory affairs community.

Ms. Joos has gained strategic as well as operational experience with European regulatory procedures and with various products in different therapeutic areas over the past two decades. She has more than 15 years of experience of working with various trade associations and professional organizations at the EU and international levels. She represents MSD in various Committees of EFPIA, EuropaBio and EUCOPE, and is actively involved in international policy activities as MSD delegate in the IFPMA Regulatory & Technical Policy Committee.

Ms. Joos has been a DIA Board member since 2014. She served as Chair of the DIA Advisory Council Europe from 2008-2015. She received the DIA Outstanding Service Award in 2013 and was Co-Chair of the DIA 2014 EuroMeeting in Vienna. She is a pharmacist by training and her main interests are related to regulatory frameworks, clinical trials environment, RA/HTA interface, pediatric development and patient involvement.

Our Leadership